Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12611448 | Targeting delivery system loaded with whole-cell components and use thereof | 🖼🧊📄§ | 2026-04-28 | 2040-11-05 | 0 | 31 |
| 12611421 | Hydroxypropyl beta-cyclodextrin compositions and methods | 🖼🧊📄§ | 2026-04-28 | 2043-12-08 | 0 | 31 |
| 12611367 | Anti-pollution composite powder having UV- and fine dust-blocking function and cosmetic composition comprising same | 🖼🧊📄§ | 2026-04-28 | 2041-03-31 | 0 | 31 |
| 12611396 | Microsphere-based injectible celecoxib formulation | 🖼🧊📄§ | 2026-04-28 | 2040-08-06 | 0 | 31 |
| 12611392 | Mitochondria-targeting antioxidants | 🖼🧊📄§ | 2026-04-28 | 2040-11-06 | 0 | 31 |
| 12611391 | Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications | 🖼🧊📄§ | 2026-04-28 | 2042-11-22 | 0 | 31 |
| 12611368 | Dry compositions and/or emulsions for chemical and physical sun protection and use thereof | 🖼🧊📄§ | 2026-04-28 | 2041-05-03 | 0 | 31 |
| 12611422 | Hydroxypropyl beta-cyclodextrin compositions and methods | 🖼🧊📄§ | 2026-04-28 | 2045-10-06 | 0 | 31 |
| 12611642 | Adapter and method of mixing constituents of a pharmaceutical complex via an adapter | 🖼🧊📄§ | 2026-04-28 | 2042-10-04 | 0 | 31 |
| 12612611 | Tetrahedral antibodies | 🖼🧊📄§ | 2026-04-28 | 2041-07-12 | 0 | 31 |
| 12612645 | AAV vectors encoding mini-PCDH15 and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-04-24 | 0 | 31 |
| 12611469 | Promoter specific for non-pigmented ciliary epithelial cells | 🖼🧊📄§ | 2026-04-28 | 2040-09-24 | 0 | 31 |
| 12611288 | Dental implant, component for dental applications, implant system for dental applications, method for forming a protective layer on the surface of an implantable or implant component, implantable or implant component having a protective layer, and use of a protective layer | 🖼🧊📄§ | 2026-04-28 | 2042-01-05 | 0 | 31 |
| 12611376 | Drug delivering stretch ring | 🖼🧊📄§ | 2026-04-28 | 2043-10-27 | 0 | 31 |
| 12612626 | siRNA compound that inhibits expression of APOC3 | 🖼🧊📄§ | 2026-04-28 | 2042-06-24 | 0 | 31 |
| 12611411 | Triple-agent therapy for cancer treatment | 🖼🧊📄§ | 2026-04-28 | 2042-09-15 | 0 | 31 |
| 12612402 | Nitrogen-containing fused heterocyclic compounds of n-sulfonamide and use thereof | 🖼🧊📄§ | 2026-04-28 | 2045-01-17 | 0 | 31 |
| 12611291 | Biosensor performance indicator systems for orthodontic appliances | 🖼🧊📄§ | 2026-04-28 | 2043-01-12 | 0 | 31 |
| 12611492 | Local drug delivery devices and methods for treating cancer | 🖼🧊📄§ | 2026-04-28 | 2044-03-29 | 0 | 31 |
| 12611468 | Recombinant adeno-associated virus vectors to target medullary thyroid carcinoma | 🖼🧊📄§ | 2026-04-28 | 2042-02-01 | 0 | 31 |
| 12611471 | Composite ferrite nanoparticle with synergistic enhancement of liver specificity and preparation method and application thereof | 🖼🧊📄§ | 2026-04-28 | 2041-02-01 | 0 | 31 |
| 12611461 | Bioorthogonal compositions | 🖼🧊📄§ | 2026-04-28 | 2045-04-16 | 0 | 31 |
| 12611462 | Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2042-07-14 | 0 | 31 |
| 12612427 | Aryl glucoside derivative, preparation method therefor and application thereof | 🖼🧊📄§ | 2026-04-28 | 2040-11-24 | 0 | 31 |
| 12612464 | Autoantibody specifically binding to NELL-1 and elevated NELL-1 polypeptide levels for identifying and treating membranous nephropathy | 🖼🧊📄§ | 2026-04-28 | 2040-09-18 | 0 | 31 |
| 12612392 | Compound, pharmaceutical compositions containing same, synthesis method therefor and use thereof | 🖼🧊📄§ | 2026-04-28 | 2045-07-07 | 0 | 31 |
| 12612598 | Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy | 🖼🧊📄§ | 2026-04-28 | 2042-06-28 | 0 | 31 |
| 12612409 | Pyrrolopyrimidines as CFTR potentiators | 🖼🧊📄§ | 2026-04-28 | 2043-04-13 | 0 | 31 |
| 12612364 | Salts and solid forms of 4-hydroxy-N,N-diisopropyltryptamine hemi-glutarate and hemi-succinate | 🖼🧊📄§ | 2026-04-28 | 2045-12-03 | 0 | 31 |
| 12612450 | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection | 🖼🧊📄§ | 2026-04-28 | 2044-02-12 | 0 | 31 |
| 12612453 | Method of treating glomerulonephritis by administering an antibody which binds and neutralizes human TGF-Beta1, TGF-Beta2 and TGF-Beta3 | 🖼🧊📄§ | 2026-04-28 | 2042-09-16 | 0 | 31 |
| 12612426 | Aryl glucoside derivative | 🖼🧊📄§ | 2026-04-28 | 2040-11-24 | 0 | 31 |
| 12612412 | Antiviral heterocyclic compounds | 🖼🧊📄§ | 2026-04-28 | 2042-04-13 | 0 | 31 |
| 12612383 | Polysubstituted pyrrolidine derivative, preparation method therefor and use thereof | 🖼🧊📄§ | 2026-04-28 | 2045-04-25 | 0 | 31 |
| 12612445 | Therapeutic agents | 🖼🧊📄§ | 2026-04-28 | 2043-09-22 | 0 | 31 |
| 12612448 | Tumor-targeting A56 protein or fragment thereof, antibody binding to A56 protein, and use thereof | 🖼🧊📄§ | 2026-04-28 | 2040-10-05 | 0 | 31 |
| 12612443 | Cell | 🖼🧊📄§ | 2026-04-28 | 2041-11-12 | 0 | 31 |
| 12612466 | Stabilized formulations containing anti-PCSK9 antibodies | 🖼🧊📄§ | 2026-04-28 | 2043-04-28 | 0 | 31 |
| 12612369 | Eco-friendly synthesis of a novel nicotinonitrile derivative (MNPN) with antibacterial and anti-inflammatory activities for preventing pressure ulcers in individuals with disabilities | 🖼🧊📄§ | 2026-04-28 | 2045-12-15 | 0 | 31 |
| 12612370 | Amino acid compositions | 🖼🧊📄§ | 2026-04-28 | 2045-01-17 | 0 | 31 |
| 12612368 | Cancer treatments targeting cancer stem cells | 🖼🧊📄§ | 2026-04-28 | 2040-11-06 | 0 | 31 |
| 12612396 | Modulators of beta catenin and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2045-11-19 | 0 | 31 |
| 12612395 | Rocaglate derivatives and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2044-10-02 | 0 | 31 |
| 12612414 | Nitrile SUMO inhibitors and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2042-07-21 | 0 | 31 |
| 12612410 | Multi-cyclic IRAK and FLT3 inhibiting compounds and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2041-12-23 | 0 | 31 |
| 12612417 | Deuterated analogues of selenophenochromenes, synthesis thereof, and methods of using same agents | 🖼🧊📄§ | 2026-04-28 | 2040-07-21 | 0 | 31 |
| 12612430 | Peptides | 🖼🧊📄§ | 2026-04-28 | 2040-09-11 | 0 | 31 |
| 12612447 | April and BAFF inhibitory immunomodulatory proteins and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2043-03-17 | 0 | 31 |
| 12612446 | CTLA-4 variant immunomodulatory proteins and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2043-01-30 | 0 | 31 |
| 12612452 | Human antibodies to bone morphogenetic protein 6 | 🖼🧊📄§ | 2026-04-28 | 2040-06-09 | 0 | 31 |